• Explore /
  • Poster
  • / Co-targeting BRAF with mTOR inhibition in solid tumors harboring <i>BRAF</i> mutations: A phase I study.

Co-targeting BRAF with mTOR inhibition in solid tumors harboring BRAF mutations: A phase I study.

Abstract Poster

Authors

Shiraj Sen

Shiraj Sen

The University of Texas MD Anderson Cancer Center, Houston, TX

Shiraj Sen , Muhammad Rizwan-ul-Haq Khawaja , Soumen Khatua , Daniel D. Karp , Filip Janku , David S. Hong , Javier Munoz , Apostolia Maria Tsimberidou , Wafik Tharwat Zaky , Patrick Hwu , Funda Meric-Bernstam , Vivek Subbiah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Other Novel Agents

Clinical Trial Registration Number

NCT01596140

Citation

J Clin Oncol 34, 2016 (suppl; abstr 2517)

DOI

10.1200/JCO.2016.34.15_suppl.2517

Abstract #

2517

Poster Bd #

217

Abstract Disclosures

Similar Posters

First Author: Meghan Mooradian

First Author: Baptiste Louveau

First Author: Zeynep Eroglu

First Author: David S. Hong